Compounds > 2-(4-(2-(2-((4-aminophenyl)methylcarbonylamino)ethylaminocarbonyl)ethyl)phenyl)ethylamino-5'-n-ethylcarboxamidoadenosine
Page last updated: 2024-12-10
2-(4-(2-(2-((4-aminophenyl)methylcarbonylamino)ethylaminocarbonyl)ethyl)phenyl)ethylamino-5'-n-ethylcarboxamidoadenosine
Description
The compound you described, **2-(4-(2-(2-((4-aminophenyl)methylcarbonylamino)ethylaminocarbonyl)ethyl)phenyl)ethylamino-5'-n-ethylcarboxamidoadenosine**, is a complex chemical structure that is likely a **synthetic analog of adenosine**. It's important to note that this is not a widely recognized or common compound, and there's very limited information available on its specific properties and biological activities.
Here's a breakdown of its structure and possible relevance to research:
**Structure:**
* **Adenosine:** The core structure of this compound is adenosine, a nucleoside that is a crucial component of DNA, RNA, and various important biological processes.
* **Modifications:** This compound has been modified in several ways:
* **Amino group on phenyl ring:** The presence of an amino group on the phenyl ring is a common modification in medicinal chemistry, often used to improve drug properties like solubility and binding affinity.
* **Ethylamino chains:** Multiple ethylamino chains linked to the phenyl ring and adenosine core suggest that this compound might be designed to target specific proteins or enzymes.
* **n-ethylcarboxamido group on the 5' position of adenosine:** This modification likely alters the compound's metabolic stability and potential for interactions with biological targets.
**Possible Research Significance:**
Given the complex structure and the presence of common medicinal chemistry modifications, this compound could be a candidate for:
* **Drug discovery:** Researchers might be investigating this compound as a potential drug lead for various therapeutic applications. The amino groups and ethylamino chains suggest possible targeting of receptors, enzymes, or other biological pathways.
* **Understanding adenosine biology:** The modifications to the adenosine molecule might allow this compound to interact with adenosine receptors in novel ways, providing insights into the complex roles of adenosine in cell signaling and various physiological processes.
* **Developing new research tools:** The compound could be used as a research tool to study specific biological processes or to develop new methods for detecting or modulating adenosine activity.
**Important Notes:**
* Without further information from the specific research context, it is difficult to determine the precise significance of this compound.
* The compound's name and structure are complex, suggesting it is likely a product of specialized research and not a commercially available chemical.
If you are interested in learning more about this specific compound, you may need to access the original research publication or contact the researchers who synthesized and studied it.
2-(4-(2-(2-((4-aminophenyl)methylcarbonylamino)ethylaminocarbonyl)ethyl)phenyl)ethylamino-5'-N-ethylcarboxamidoadenosine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 3081715 |
MeSH ID | M0168878 |
Synonyms (7)
Synonym |
124190-27-8 |
beta-d-ribofuranuronamide, 1-(6-amino-2-((2-(4-(3-((2-(((4-aminophenyl)acetyl)amino)ethyl)amino)-3-oxopropyl)phenyl)ethyl)amino)-9h-purin-9-yl)-1-deoxy-n-ethyl- |
2-(4-(2-(2-((4-aminophenyl)methylcarbonylamino)ethylaminocarbonyl)ethyl)phenyl)ethylamino-5'-n-ethylcarboxamidoadenosine |
papa-apec |
(2s,3s,4r,5r)-5-[6-amino-2-[2-[4-[3-[2-[[2-(4-aminophenyl)acetyl]amino]ethylamino]-3-oxopropyl]phenyl]ethylamino]purin-9-yl]-n-ethyl-3,4-dihydroxyoxolane-2-carboxamide |
DTXSID60154235 |
2-(4-(2-(2-((4-aminophenyl)methylcarbonylamino)ethylaminocarbonyl)ethyl)phenyl)ethylamino-5'-n-ethy |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.01
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 13.01 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 5.09 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |